×

Sign In

Search
Home

Merck discontinues development of 2 cancer drugs after trial failures

By Thomson Reuters Dec 16, 2024 | 3:38 PM

(Reuters) – Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.

(Reporting by Leroy Leo in Bengaluru; Editing by Alan Barona)

Chevron Australia signs long-term gas supply deal with Alcoa

Taipei mayor calls for reduced tensions during rare visit of Chinese officials

Orioles sign Japanese RHP Tomoyuki Sugano

Walmart China partners with Chinese delivery giant Meituan

Asian shares drift, dollar firms ahead of central bank meetings

South Korea acting president Han calls for speedy implementation of 2025 budget

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2024. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.